Torrent to pay $324m for Elder's branded formulations business, beating fancier rivals

Torrent Pharmaceuticals has acquired the branded domestic formulations business of the Indian firm, Elder Pharmaceuticals, for INR20bn ($323.5m), ending months of speculation of an imminent deal and apparently pipping fancier suitors, such as Sanofi, along the way.